Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.
- Published in:
- Hepatitis Monthly, 2015, v. 15, n. 9, p. 1, doi. 10.5812/hepatmon.28879
- By:
- Publication type:
- Article